[go: up one dir, main page]

ECSP044984A - Oxidación del c-14 de derivados de la morfina - Google Patents

Oxidación del c-14 de derivados de la morfina

Info

Publication number
ECSP044984A
ECSP044984A EC2004004984A ECSP044984A ECSP044984A EC SP044984 A ECSP044984 A EC SP044984A EC 2004004984 A EC2004004984 A EC 2004004984A EC SP044984 A ECSP044984 A EC SP044984A EC SP044984 A ECSP044984 A EC SP044984A
Authority
EC
Ecuador
Prior art keywords
benzyl
morphine
oxidation
derivatives
oxidant
Prior art date
Application number
EC2004004984A
Other languages
English (en)
Inventor
Joannes Theodorus Maria Linders
Pieter Vrijhof
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ECSP044984A publication Critical patent/ECSP044984A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de un derivado de 14 hidroxinormorfinona de la fórmula IV, que comprende la reacción del compuesto de la fórmula III con un oxidante de cobalto (II) en presencia de una base suave y aire u oxígenocomo co-oxidante; en donde R1 es (1C-7C)alquilo, sustituido opcionalmente por una o más clorinas, por butenilo, vinilo, bencilo, fenilo o naftilo; y R2 es bencilo o bencilo sustituido por uno o más sustituyentes del grupo (1C-6C)alcoxi o bencilo sustituido por uno o más halógenos. El proceso es muy adecuado para la producción de noroximorfona.
EC2004004984A 2001-08-23 2004-02-19 Oxidación del c-14 de derivados de la morfina ECSP044984A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01203187 2001-08-23

Publications (1)

Publication Number Publication Date
ECSP044984A true ECSP044984A (es) 2004-04-28

Family

ID=8180821

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004004984A ECSP044984A (es) 2001-08-23 2004-02-19 Oxidación del c-14 de derivados de la morfina

Country Status (25)

Country Link
US (1) US7435817B2 (es)
EP (1) EP1421085B1 (es)
JP (1) JP4559730B2 (es)
KR (1) KR100901402B1 (es)
CN (1) CN1271072C (es)
AR (1) AR035289A1 (es)
AT (1) ATE466016T1 (es)
AU (1) AU2002331163B2 (es)
BR (1) BRPI0211899B8 (es)
CA (1) CA2457671C (es)
DE (1) DE60236171D1 (es)
EC (1) ECSP044984A (es)
ES (1) ES2345327T3 (es)
HR (1) HRP20040161A2 (es)
HU (1) HUP0401600A3 (es)
IL (1) IL160193A0 (es)
IS (1) IS7153A (es)
MX (1) MXPA04001647A (es)
NO (1) NO328655B1 (es)
NZ (1) NZ531152A (es)
PE (1) PE20030460A1 (es)
PL (1) PL368732A1 (es)
RU (1) RU2297419C2 (es)
WO (1) WO2003018588A2 (es)
ZA (1) ZA200401016B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126529A1 (ja) * 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
AU2006259780B2 (en) * 2005-06-16 2012-04-12 SpecGx LLC A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
WO2008118654A1 (en) * 2007-03-23 2008-10-02 Mallinckrodt Inc. Improved preparation of oxymorphone from oripavine
CN101033228B (zh) * 2007-04-04 2010-05-19 复旦大学 14-羟基-7,8-二氢降吗啡酮的制备方法
ES2423180T3 (es) 2007-04-16 2013-09-18 Mallinckrodt Llc Nueva reducción de opiáceos mediante reacción de transferencia de hidrógeno catalítica
WO2009078988A1 (en) * 2007-12-17 2009-06-25 Mallinckrodt Inc. Sinomenine derivatives and processes for their synthesis
CN101896487A (zh) 2007-12-17 2010-11-24 马林克罗特公司 N-甲基吗啡喃的n-脱甲基化
CN101896463B (zh) * 2007-12-17 2016-08-24 马林克罗特有限公司 制备(+)阿片类的方法和化合物
AU2011252041B2 (en) 2010-05-10 2014-04-03 Euro-Celtique S.A. Combination of active loaded granules with additional actives
EP2568968B1 (en) 2010-05-10 2017-07-12 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
CA2739751C (en) 2010-05-10 2014-08-12 Euro-Celtique, S.A. Pharmaceutical compositions comprising hydromorphone and naloxone
WO2011154827A2 (en) 2010-06-11 2011-12-15 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
JP2013529595A (ja) 2010-06-11 2013-07-22 ローズ テクノロジーズ 第３級アミンのｎ−脱アルキル化方法
CA2845187A1 (en) 2011-09-08 2013-03-14 Peter X. Wang Production of alkaloids without the isolation of intermediates
EP3027622B8 (en) * 2013-08-02 2019-06-12 Johnson Matthey Public Limited Company Process for the preparation of oxymorphone
NZ719087A (en) 2013-11-13 2017-12-22 Euro Celtique Sa Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
CN114621238A (zh) * 2020-12-10 2022-06-14 鲁南制药集团股份有限公司 一种制备纳呋拉啡的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158476B1 (en) 1984-03-27 1991-01-23 Mallinckrodt, Inc. (a Delaware corporation) Preparation of noroxymorphone from morphine
US5112975A (en) * 1984-03-27 1992-05-12 Mallinckrodt Specialty Chemicals Company Preparation of noroxymorphone from morphine
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
WO2000066588A1 (en) * 1999-05-05 2000-11-09 The Government Of The United States Of America, Represented By The Secretary, Departmentof Health A Nd Human Services Direct c-14 oxidation of opioids

Also Published As

Publication number Publication date
CA2457671C (en) 2011-02-15
NZ531152A (en) 2005-11-25
AR035289A1 (es) 2004-05-05
WO2003018588A2 (en) 2003-03-06
ES2345327T3 (es) 2010-09-21
PL368732A1 (en) 2005-04-04
CN1271072C (zh) 2006-08-23
DE60236171D1 (de) 2010-06-10
HUP0401600A3 (en) 2008-05-28
KR100901402B1 (ko) 2009-06-05
IL160193A0 (en) 2004-07-25
NO20040724L (no) 2004-02-19
HUP0401600A2 (hu) 2004-11-29
KR20040027950A (ko) 2004-04-01
ZA200401016B (en) 2004-10-19
EP1421085B1 (en) 2010-04-28
WO2003018588B1 (en) 2004-02-26
RU2004108210A (ru) 2005-04-10
EP1421085A2 (en) 2004-05-26
AU2002331163B2 (en) 2008-02-21
RU2297419C2 (ru) 2007-04-20
US7435817B2 (en) 2008-10-14
BRPI0211899B8 (pt) 2021-05-25
HK1063803A1 (en) 2005-01-14
JP4559730B2 (ja) 2010-10-13
HRP20040161A2 (en) 2004-06-30
PE20030460A1 (es) 2003-05-15
CN1545517A (zh) 2004-11-10
IS7153A (is) 2004-02-13
JP2005502670A (ja) 2005-01-27
US20050038250A1 (en) 2005-02-17
ATE466016T1 (de) 2010-05-15
BR0211899B1 (pt) 2014-01-21
CA2457671A1 (en) 2003-03-06
WO2003018588A3 (en) 2003-11-27
BR0211899A (pt) 2004-09-21
NO328655B1 (no) 2010-04-19
MXPA04001647A (es) 2004-05-31

Similar Documents

Publication Publication Date Title
ECSP044984A (es) Oxidación del c-14 de derivados de la morfina
PT2428519E (pt) Processo para preparação de 17-o-vinil-triflatos como intermediários
ZA200804218B (en) Process for the manufacture of epoxybutanol intermediates
PE20021004A1 (es) Derivados de piperidina como inhibidores de la ccr5
ECSP056012A (es) Proceso para preparar derivados de feniltilamina
AR052915A1 (es) Derivados de pirrolidin y piperidin acetileno
AR053890A1 (es) Proceso para la sintesis de derivados de piridinil-pirimidinilo
ATE402173T1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
AR039935A1 (es) Formulacion farmaceutica de liberacion inmediata
BRPI0411195A (pt) método para a preparação de uma oxazinona fundida e método para a preparação de um composto
EP1283197A4 (en) PROCESS FOR THE PRODUCTION OF CINNAMYL ALDEHYDE DERIVATIVES AND THEIR USE
DE60006857D1 (de) Verfahren zur herstellung von pyridinmethanol-verbindungen
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
UY26388A1 (es) Procedimiento para la preparacion de compuestos de pirazolo (4,3-d) pirimidin - 7-onas-3- piridilsulfonilo e intermedios de los mismos.
DE60223862D1 (de) Verfahren zur Herstellung von Terbinafine
IL193276A0 (en) Process for preparing 1-halo-2,7-naphthyridinyl derivatives
EP1262476A4 (en) METHOD FOR PRODUCING QUINOLIN DERIVATIVES AND THEIR INTERMEDIATE STAGES
CO4980899A1 (es) Proceso para la sintesis de los compuestos intermediarios de cloropurina
MXPA05013604A (es) Procedimiento para preparar acilsulfamoilbenzamidas.
AR047686A1 (es) Un procedimiento de sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable
AR054874A1 (es) Metodo para producir un derivado de 5- hidroxi -1-alquilpirazol
TW200621726A (en) Production method of pyrimidine compounds
GT200200250A (es) Compuestos hexaciclicos
AR008526A1 (es) Procedimiento para preparar eteres bencilicos.
AR039384A1 (es) Proceso para la preparacion de sales de dicetonas biciclicas